BG
IART icon

Bellevue Group’s Integra LifeSciences IART Stock Holding History

Bellevue Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-122,426
Closed -$5.78M – 225
2020
Q3 		$5.78M Sell
122,426
-78,471
-39% -$3.73M 0.08% 125
2020
Q2 		$9.44M Buy
200,897
+3,477
+2% +$171K 0.13% 110
2020
Q1 		$8.82M Sell
197,420
-60,352
-23% -$3.17M 0.17% 91
2019
Q4 		$15M Buy
257,772
+44,215
+21% +$2.63M 0.24% 73
2019
Q3 		$12.8M Buy
213,557
+21,824
+11% +$1.3M 0.24% 75
2019
Q2 		$10.7M Sell
191,733
-30,617
-14% -$1.58M 0.18% 83
2019
Q1 		$12.4M Buy
222,350
+76,571
+53% +$3.9M 0.68% 47
2018
Q4 		$6.58M Buy
145,779
+4,159
+3% +$228K 0.43% 57
2018
Q3 		$9.33M Buy
141,620
+83,459
+143% +$5.19M 0.59% 53
2018
Q2 		$3.75M Sell
58,161
-132,839
-70% -$8.23M 0.32% 61
2018
Q1 		$10.6M Buy
191,000
+8,800
+5% +$461K 1.05% 37
2017
Q4 		$8.72M Buy
182,200
+5,350
+3% +$262K 0.91% 44
2017
Q3 		$8.93M Buy
176,850
+16,500
+10% +$847K 0.93% 38
2017
Q2 		$8.74M Buy
160,350
+145,350
+969% +$6.94M 1.03% 39
2017
Q1 		$632K Buy
+15,000
New +$641K 0.08% 117

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group's IART Position: Q4 2020 in Review

Bellevue Group sold out of Integra LifeSciences (IART) in Q4 2020, closing a stake of 122,426 shares — an estimated $5.78M sold.

Bellevue Group first reported a position in IART in Q1 2017 and held it in 15 quarters. The position peaked at $15M in Q4 2019. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • Bellevue Group reported no remaining Integra LifeSciences position as of Q4 2020 after selling out during the quarter.
  • Bellevue Group sold 122,426 Integra LifeSciences shares in Q4 2020, an estimated $5.78M.
  • Bellevue Group first reported a position in Integra LifeSciences in Q1 2017 and held it in 15 quarters.
  • Bellevue Group's Integra LifeSciences position peaked at $15M in Q4 2019.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on Bellevue Group's 13F filing for Q4 2020, filed 16 Feb 2021.